News

He had six months to live. Then came an experimental cancer treatment launched by Harvard researchers.
The hunt for a medical breakthrough has been caught up in the Trump administration's political assault on the university.
The American Journal of Managed Care3d
FDA Approves Sunvozertinib in Non–Small Cell Lung Cancer
The treatment marks the only targeted oral treatment in patients with non–small cell lung cancer with epidermal growth factor ...
The Malaysian Reserve6h
Cancer Innovation Accelerates as Funding Cuts Loom and Biotechs Step Up
USA News Group News CommentaryIssued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, July 10, 2025 /PRNewswire/ -- USA News Group News Commentary – ...
USA News Group: Cancer Innovation Accelerates as Funding Cuts Loom and Biotechs Step Up
USA News Group News CommentaryIssued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, July 10, 2025 /PRNewswire/ -- USA News Group News Commentary - Cancer rates are rising everywhere ...
Frontiers13d
Endocrine Immune-Related Toxicities during Treatment of Lung Cancer with Immune Checkpoint Inhibitors
Lung cancer remains the leading cause of cancer mortality worldwide. Immunotherapy has recently emerged as a promising therapeutic strategy both for ...
Pulmonology Advisor13d
ASCO 2025: Therapies Outperform, Improve Upon Chemo in NSCLC
Targeted therapies and immunotherapy can provide benefits when added to chemotherapy or may eliminate the need for ...
Frontiers13d
Artificial Intelligence Advancing Lung Cancer Screening and Treatment
Lung cancer is the leading cause of cancer-related mortality globally. Although low-dose computed tomography (LDCT) has shown ...
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers
Each year, approximately 20 million people are diagnosed with cancer, and nearly 10 million lives are lost to the disease ...
Breaking Through: Systemic Genetic Medicines For Hard-To-Treat Cancers - Financial News Media
Calidi Biotherapeutics Inc. has spent over 10 years developing a groundbreaking platform for the systemic delivery of genetic medicines that can precisely target tumors. One of the company's core ...
The Healthy @Reader's Digest on MSN3d
Researchers Just Found That Your Gut Could Help Diagnose a Seemingly Unconnected Cancer
Researchers in China say the bacteria in your gut—and beyond—may play a role in your chance of developing one of the leading ...
Pharmabiz5d
AstraZeneca’s Imfinzi receives European approval to treat patients with resectable muscle-invasive bladder cancer
AstraZeneca’s Imfinzi receives European approval to treat patients with resectable muscle-invasive bladder cancer: Cambridge, UK Saturday, July 5, 2025, 09:00 Hrs [IST] AstraZen ...